Active substance

Haemagglutininum influenzae A (H1N1) (Virus Stamm A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) + Haemagglutininum influenzae A (H3N2) (Virus Stamm A/Croatia/10136RV/2023 (H3N2)-like: reassortant virus X-425A derived from A/Croatia/10136RV/2023) + Haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant virus BVR-26 derived from B/Austria/1359417/2021 (Victoria lineage))

1 products from 1 companies contain this in Switzerland.

1 prescription only

Prescription only

Fluarix Tetra 15 µg / 0.5 ml15 µg / 0.5 mlPrescription only GlaxoSmithKline AG · Haemagglutininum influenzae A (H1N1) (Virus Stamm A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) + Haemagglutininum influenzae A (H3N2) (Virus Stamm A/Croatia/10136RV/2023 (H3N2)-like: reassortant virus X-425A derived from A/Croatia/10136RV/2023) + Haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant virus BVR-26 derived from B/Austria/1359417/2021 (Victoria lineage)) · J07BB02

Same substance is not the same product. Strength, form, release mechanism and other ingredients all differ. Whether one can replace another is a decision for a pharmacist.